Press release
Panic Disorders Market 2024 - Share, Ongoing Trends, Size, Growth Rate And Key Players
Panic Disorders Market
The Business Research Company offers in-depth market insights through Panic Disorders Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The panic disorders market size has grown strongly in recent years. It will grow from $10.19 billion in 2023 to $10.73 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to antidepressant medications, increased mental health awareness, increased stress levels, access to mental health services, advancements in diagnostic criteria..
The panic disorders market size is expected to see strong growth in the next few years. It will grow to $13.07 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging pharmacological treatments, telepsychiatry services, focus on comorbidities, global mental health initiatives, pharmacogenomics in treatment, public education programs.. Major trends in the forecast period include digital mental health interventions, telemedicine for panic disorder treatment, innovations in medications, neurobiological research, remote monitoring and wearable technology..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp
Market Segmentation:
The panic disorders market covered in this report is segmented -
1) By Type: Agoraphobia, Social Anxiety Disorder (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder
2) By Treatment: Medication, Beta Blockers, Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs), Benzodiazepines, Anti-Epilepsy, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By End Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores
Major Driver - Rising Number Of Psychiatric Patients Expected To Drive Panic Disorder Market Growth
An increase in the number of psychiatric patients is expected to propel the growth of the panic disorder market going forward. Psychiatric patients are individuals afflicted by psychiatric disorders or mental illnesses, which can disrupt cognition, emotions, and social behavior, resulting in panic disorder or panic attacks marked by sudden intensity. Treatment for psychiatric patients with panic disorder typically involves a combination of therapeutic approaches, medication, and lifestyle changes to alleviate the symptoms of panic attacks, improve the patient's overall quality of life, and help them manage and cope with condition effectively. For instance, in October 2022, according to the State of Mental Health in America 2022 report published by Mental Health America, a US-based non-profit organization associated with mental health promotion, the number of psychiatric patients or adults with any mental illnesses increased to 49,564,000, representing 19.86% of the total US population in 2022, compared with 47,132,000, representing 19.00% of the total US population in 2021. Therefore, the increase in the number of psychiatric patients will drive the growth of the panic disorder market.
Competitive Landscape:
Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd, Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc, Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd, VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report
Top Trend - Pharmaceutical Companies Focus On Extended-Release Capsules For Panic Disorder Treatment Advancements
Major companies operating in the panic disorder market are focusing on developing advanced medicines, such as extended-release capsules, to sustain their position in the market. Extended-release capsules are medications that release the active ingredient slowly over a while, typically 12 or 24 hours, to treat conditions requiring medication to be taken over a long period. For instance, in May 2023, Granules India Ltd., an India-based pharmaceutical company, received abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for Venlafaxine hydrochloride extended-release capsules. It demonstrates bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed for the management of conditions including generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They work by increasing the levels of serotonin and norepinephrine in the brain, and the dosage is usually started at 75 mg per day and may be increased by the doctor as needed.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Panic Disorders Market Characteristics
3. Panic Disorders Market Trends And Strategies
4. Panic Disorders Market - Macro Economic Scenario
5. Panic Disorders Market Size And Growth
…..
27. Panic Disorders Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Panic Disorders Market 2024 - Share, Ongoing Trends, Size, Growth Rate And Key Players here
News-ID: 3435867 • Views: …
More Releases from The Business research company
Leading Companies Reinforcing Their Presence in the Silica Mineral Supplements M …
The silica mineral supplements market is gaining notable traction as consumers increasingly prioritize health and wellness. With rising interest in preventive care and new technological advancements, this sector is set for significant expansion. Let's explore the market's size, key drivers, leading companies, emerging trends, and the main segments shaping its future.
Market Size and Growth Outlook for the Silica Mineral Supplements Market
The silica mineral supplements market is projected to experience robust…
Global Trends Overview: The Fast-Paced Evolution of the Seed Protein Supplements …
The seed protein supplements market is gaining significant traction as consumers increasingly seek plant-based nutrition options. With evolving dietary preferences and technological advancements, this sector is poised for remarkable growth through the end of the decade. Below, we explore the market's size, key players, driving factors, trends, and segmentation to understand its future potential.
Projected Expansion of the Seed Protein Supplements Market Size Through 2029
The seed protein supplements market is set…
Market Structure, Emerging Trends, and Key Player Analysis in the Robotic Weldin …
The robotic welding fume extraction system market is rapidly evolving as industries prioritize safer and cleaner working environments. With the increasing use of robotic welding technologies and a focus on sustainable manufacturing, this sector is poised for significant growth. The following overview highlights the market's value projections, key players, prevailing trends, and segmentation details shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Robotic Welding Fume Extraction System…
Major Industry Participants Reinforcing Their Presence in the Robotic Biobanking …
The robotic biobanking systems sector is experiencing swift advancements, driven by growing needs in precision medicine and large-scale research initiatives. As automation becomes increasingly integral to laboratory operations, this market is set to expand significantly, offering promising opportunities and innovations in the years ahead. Let's explore the market size projections, key players, emerging trends, and segmentation details shaping this dynamic industry.
Expected Growth in the Robotic Biobanking Systems Market by 2029
The…
More Releases for Disorder
Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate?
The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to…
Autism Spectrum Disorder Therapeutics Market: "Autism Spectrum Disorder Therapie …
Autism Spectrum Disorder Therapeutics Market Scope:
Key Insights : Autism Spectrum Disorder Therapeutics Market size was valued at USD 1.92 billion in 2022 and is poised to grow from USD 2.07 billion in 2023 to USD 3.77 billion by 2031, growing at a CAGR of 7.80% during the forecast period (2024-2031).
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/autism-spectrum-disorder-therapeutics-market
In-Depth Exploration of the global Autism Spectrum Disorder Therapeutics …
Bipolar Disorder Therapeutics Market Report 2024 - Bipolar Disorder Market Oppor …
"The Business Research Company recently released a comprehensive report on the Global Bipolar Disorder Therapeutics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Bipolar Disorder Therapeutics Market: Balancing the Mind - Unveiling Breakthroug …
Allied Market Research recently said Bipolar disorder, a mental health condition characterized by extreme shifts in mood and energy levels, affects millions of people worldwide. The quest for effective therapeutics to manage this complex disorder has seen remarkable progress in recent years. This article explores the innovative developments in bipolar disorder therapeutics, shedding light on the path to achieving a harmonious balance for those living with this condition.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞…
Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior.
Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors…
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms…
